Middle East

African countries acquiring mRNA vaccine technology in WHO project

(LR) President of Nigeria Muhammadu Buhari, President of the European Commission Ursula von der Leyen, President of Egypt Abdel Fatta El Sissi, President of South Africa, Cyril Ramaphosa, Chairman of the African Union of Senegal, McKee Sole, Europe Council Chair Charles Michel, French President Emmanuel Macron, President Kenya, Uhru Kenyatta, President Tunisia, Kais Sayed, and WHO Secretary-General Dr. Tedros Adanom Gebreez at the European Union (EU) African Union (AU) Summit The European Council Building in Buhari yesterday, posing at the beginning of the second day of the month.

The World Health Organization announced yesterday that six African countries (Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia) will be the first on the African continent to receive the technology needed to produce mRNA vaccines.
The technology transfer project, launched last year in Cape Town, aims to help low- and middle-income countries produce mRNA vaccines on a large scale and in accordance with international standards.
mRNA is an advanced technology used by companies such as Pfizer-BioNTech and Moderna for Covid-19 shots.
WHO established a global mRNA technology transfer hub after purchasing large vaccines in favor of selling to governments where wealthy countries and businesses are likely to pay the highest prices.
This put low- and middle-income countries behind the queue for the Covid-19 vaccine.
Last June, WHO selected a consortium of South African companies to operate a global mRNA hub, and Afrigen Biologics later created its own version of a U.S. company’s Covid Shot using Moderna’s publicly available vaccine sequence. did.
According to WHO, the initial approval of doses by Afrigen may only occur in 2024.
WHO Executive Secretary Tedros Adhanom Ghebreyesus said the pandemic showed more than any other event that relying on a small number of companies to supply the world’s public goods was limiting and dangerous. “In the medium to long term, the best way to deal with health emergencies and reach universal health insurance is to significantly increase the capacity of all regions to produce the health products they need,” he said. Said in a statement.
South African President Cyril Ramaphosa has asked Covax, a global vaccine distribution program, and Gavi, a vaccine alliance, to purchase vaccines from local manufacturing sites.
“The lack of a market for vaccines produced in Africa is of concern to all of us,” Ramaphosa said at a bystander meeting at the European Union-African Union (AU) Summit in Brussels.
“Organizations such as Covax and Gavi need to promise to buy vaccines from local manufacturers rather than going out of the hub where they are installed.”
“Of course, our goal is to administer 60% of the vaccine in Africa … to produce it in Africa,” said Senegalese President Macky Sall.
Jolande Makoro, a spokeswoman for the Rwandan government, told Reuters that the government is working with BioNTech, WHO and AU to produce mRNA vaccines.
Makoro did not directly answer whether Rwanda had applied for part of WHO’s technology transfer project.
Hub has already established laboratory-scale production of mRNA vaccines and is working towards commercial production.
Training in the host country will begin in March 2022.
“This is an mRNA technology designed in Africa, led by Africa and owned by Africa with the support of Team Europe,” said Ursula von der Reyen, President of the European Commission.
Transfer hubs, primarily in response to Covid-19 emergencies, have the potential to expand manufacturing capacity to combat diseases such as tuberculosis and malaria in Africa.

http://www.gulf-times.com/story/710142/African-countries-to-get-mRNA-vaccine-tech-in-WHO- African countries acquiring mRNA vaccine technology in WHO project

Back to top button